1. Home
  2. NXRT vs EOLS Comparison

NXRT vs EOLS Comparison

Compare NXRT & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Residential Trust Inc.

NXRT

NexPoint Residential Trust Inc.

HOLD

Current Price

$17.70

Market Cap

469.4M

Sector

Real Estate

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.63

Market Cap

500.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXRT
EOLS
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.4M
500.0M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
NXRT
EOLS
Price
$17.70
$7.63
Analyst Decision
Hold
Buy
Analyst Count
6
6
Target Price
★ $25.25
$15.00
AVG Volume (30 Days)
519.3K
★ 669.0K
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 11.54%
N/A
EPS Growth
N/A
★ 1.23
EPS
N/A
★ N/A
Revenue
$251,281,000.00
★ $297,176,000.00
Revenue This Year
$2.06
$12.44
Revenue Next Year
$2.37
$17.37
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$17.67
$3.86
52 Week High
$32.36
$9.31

Technical Indicators

Market Signals
Indicator
NXRT
EOLS
Relative Strength Index (RSI) 35.91 51.57
Support Level N/A $7.59
Resistance Level $20.22 $7.83
Average True Range (ATR) 0.66 0.32
MACD 0.10 0.02
Stochastic Oscillator 8.31 79.57

Price Performance

Historical Comparison
NXRT
EOLS

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: